Clinic of Urology, CCM

Projects

• A Double-blind, Placebo-Controlled Dose-Optimization, Safety and Efficacy Study
• Collaboration with Nankai University, Tianjin, P.R. China
• Combination therapy with Docetaxel/Estramustin in hormone refractory prostate cancer (HRPC)
• Fc Receptors for IgG in prostate cancer
• Identification of patients with prostate cancer risk by analysis of TP53 mutation status
• Immunomodulation by laparoscopic kidney harvesting ?
• Improtance of laparoscopic operations in uro-oncology
• Isoforms of prostate specfic antigen in prostatic tissue and serum
• Kombination insterstitieller Hyperthermie und konformaler Strahlentherapie bei der Behandlung lokalen ProstataCa
• Lycopene and prostate cancer
• MMP inhibitors
• MMPs in seminal plasma
• Matrix metalloproteinases in prostate cancer
• Optical coherenctomography (OCT) in bladder cancer patients (in vivo)
• Photocure Hexvix Study PCB 303/01in patient with bladder cancer
• Protein analysis in urology
• Randomised, open labelled, comparative study of TAP-144-SR (1M) and TAP-144-SR (4M) in patients with advanced prost
• Real-time PCR of MT-MMPs at the LigthCycler
• Separation of subforms of free PSA
• Special cystoscope for in vivo imaging and diagnosis of superficiale bladder cancer
• Subforms of free PSA: analytical and clinical validation
• Tumor marker in urology
• fPSA and 2D-electrophoresis

If the list does not contain any entry, the request was executed without results